• Explore /
  • Poster
  • / Sequential treatment with gemcitabine/nab-paclitaxel (GA) and FOLFIRINOX (FFX) followed by stereotactic MRI-guided adaptive radiation therapy (SMART) in patients with locally advanced pancreatic cancer (LAPC): GABRINOX-ART phase 2, multicenter trial.

Sequential treatment with gemcitabine/nab-paclitaxel (GA) and FOLFIRINOX (FFX) followed by stereotactic MRI-guided adaptive radiation therapy (SMART) in patients with locally advanced pancreatic cancer (LAPC): GABRINOX-ART phase 2, multicenter trial.

Abstract Poster

Authors

null

Fabienne Portales

Institut du Cancer de Montpellier (ICM), Univ Montpellier, Montpellier, France

Fabienne Portales , Marc Ychou , Emmanuelle Samalin , Eric Assenat , Stephane Obled , Marguerite Tyran , Emmanuel Mitry , Magali Rouffiac , François Ghiringhelli , Jean-Baptiste Bachet , Jean-Marc Simon , Mark De Ridder , Catherine Fiess , Aurore Moussion , Stephanie Delaine , Florin Grigorescu , Sophie Gourgou , Olivier Riou

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT04570943

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS4191)

DOI

10.1200/JCO.2022.40.16_suppl.TPS4191

Abstract #

TPS4191

Poster Bd #

160b

Abstract Disclosures

Similar Posters

First Author: Fabienne Portales

First Author: Masato Ozaka

First Author: Anna M. Varghese

First Author: Akira Fukutomi